AMY CARTER: Open Payments
NPI 1215302336 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 76 payments from 16 companies in 2025. Trend: 2023 $1,552 · 2024 $1,492 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $400 |
| Tandem Diabetes Care, Inc. | 3 | $370 |
| Novartis Pharmaceuticals Corporation | 10 | $256 |
| Novo Nordisk Inc | 8 | $210 |
| Madrigal Pharmaceuticals | 3 | $116 |
| Abbott Laboratories | 6 | $111 |
| Xeris Pharmaceuticals, Inc. | 5 | $110 |
| Medtronic, Inc. | 5 | $84 |
| Alexion Pharmaceuticals, Inc. | 2 | $56 |
| Corcept Therapeutics | 2 | $44 |
Products named: t:slim X2 Insulin Pump with Control-IQ, EVENITY, LEQVIO, REZDIFFRA, Wegovy, FREESTYLE LIBRE 3, MINIMED 780G, Ozempic.
Industry payments across OR — which companies pay providers there.
